Home › Funds › ProShares › ProShares Pet Care ETF
Fund family: ProShares · Filed by PROSHARES TRUST (CIK 1174610) · SEC series S000062559
Ticker: PAWZ (C000202974)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 297 with, 10 against, 0 abstentions (not counted as with management). Shareholder proposals: 4 FOR, 5 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as ProShares’s manager page (303,945 ballot items across 135 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | ProShares | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 85.6% | 278 | 91.4% | 279,029 |
| Backed environmental and social shareholder proposals at US companies | n/a | 5 | 10.6% | 4,043 |
Each ballot item this fund voted is set against the votes of the other ProShares funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most ProShares funds on all 189 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 64.5% of this fund’s 307 such votes could be given a sector; the other 109 (35.5%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 72 | 5 | 6.9% |
| Consumer Discretionary | 65 | 2 | 3.1% |
| Consumer Staples | 52 | 2 | 3.8% |
| Miscellaneous | 9 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 200 | 0 |
| Audit-related | 24 | 0 |
| Compensation | 22 | 0 |
| Corporate Governance | 22 | 5 |
| Say-on-Pay | 18 | 0 |
| Capital Structure | 15 | 0 |
| Environment or Climate | 4 | 4 |
| Other Social Issues | 2 | 1 |
| Shareholder Rights and Defenses | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| IDEXX Laboratories, Inc. | May 12, 2026 | $5M | 8 | 1 |
| Freshpet, Inc. | June 10, 2026 | $4M | 14 | 0 |
| Chewy, Inc. | July 10, 2025 | $3M | 6 | 0 |
| Zoetis Inc. | May 20, 2026 | $3M | 16 | 1 |
| Trupanion, Inc. | June 10, 2026 | $3M | 11 | 0 |
| Merck & Co., Inc. | May 26, 2026 | $2M | 18 | 3 |
| Oil-Dri Corporation of America | December 9, 2025 | $2M | 10 | 0 |
| Petco Health and Wellness Company, Inc. | July 24, 2025 | $1M | 5 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 12, 2026 | IDEXX Laboratories, Inc. | Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). Shareholder proposal | For | Against |
| May 20, 2026 | Zoetis Inc. | Shareholder proposal to permit shareholder action by written consent. Shareholder proposal | For | Against |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| May 8, 2026 | Colgate-Palmolive Company | Stockholder proposal entitled "Remove DEI from Board Candidate Considerations." Shareholder proposal | Against | For |
| May 8, 2026 | Colgate-Palmolive Company | Stockholder proposal entitled "Independent Board Chairman." Shareholder proposal | Against | For |
| September 30, 2025 | General Mills, Inc. | Shareholder Proposal - Disclosure of Regenerative Agriculture Practices Within Supply Chain. Shareholder proposal | For | Against |
| September 30, 2025 | General Mills, Inc. | Shareholder Proposal - Adopt Policy to Separate the Board Chair and CEO Roles. Shareholder proposal | For | Against |
| April 16, 2026 | Nestle SA | Transact Other Business (Voting) | Against | For |
308 ballot items at 24 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, ProShares Pet Care ETF (PAWZ) voted at 24 shareholder meetings of 23 companies, on 308 ballot items in all. Where management made a recommendation, the fund followed it on 96.7% of the items and voted against it 10 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 9 shareholder proposals. It voted FOR the board's own proposals less often than ProShares's funds as a whole (85.6% against 91.4%). It voted the same way as most ProShares funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of ProShares’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.